e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Infection, sepsis and outcomes in ICU
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Discrimination of sepsis metabolic profiles revealed by LC/MS-MS based metabonomics approach
L. Su, Y. Huang, Y. Zhu, K. Xiao, L. Cao, L. Xie (Sanyan, Tianjin, Beijing, Shenzhen, China)
Source:
Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Session:
Infection, sepsis and outcomes in ICU
Session type:
Thematic Poster Session
Number:
2444
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Su, Y. Huang, Y. Zhu, K. Xiao, L. Cao, L. Xie (Sanyan, Tianjin, Beijing, Shenzhen, China). Discrimination of sepsis metabolic profiles revealed by LC/MS-MS based metabonomics approach. Eur Respir J 2013; 42: Suppl. 57, 2444
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Indications and pitfalls of high-flow nasal cannula (HFNC) outside the intensive care unit
Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: results of a 5-year follow-up cohort study
Problems and non-adherence to NIV in intensive care
Related content which might interest you:
Preliminary proteomics analysis for sepsis biomarkers with iTRAQ labeling and LC-MS/MS
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013
High-throughput analysis of induced sputum from the U-BIOPRED study using novel proteomic and data mining approaches
Source: Annual Congress 2013 –Origins and diagnosis of asthma
Year: 2013
Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Proteome fingerprints define groups with distinct clinico-pathological phenotypes in the U-BIOPRED asthma study
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Sputum supernatant profiling reveals inflammasome-associated signatures in severe asthmatics in U-BIOPRED
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015
Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Metabolomic profiling differences among asthma, COPD and healthy controls: a LC-MS-based metabolomics analysis
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019
New approaches to tuberculosis diagnosis through the study of metabolomic profile in urine
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
Metabolomic fingerprinting in the identification of biomarkers in COPD patients
Source: Annual Congress 2012 - Basic and translational studies in COPD
Year: 2012
Unbiased cluster analysis of severe asthma based on metabolomics by the U-BIOPRED electronic nose platform
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
Mass spectrometry methods for biomarker research for chronic lung allograft dysfunction (CLAD) in systems prediction of CLAD (SysCLAD)
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
A multi-omics data integration approach to identify a predictive molecular signature of CLAD
Source: International Congress 2015 – Predictors of lung transplant complications
Year: 2015
Large-scale quantitative proteomic analysis identifies pathways in COPD-associated lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
Benchtop NMR-based metabolomic analysis as a diagnostic tool for tuberculosis in clinical urine samples
Source: International Congress 2019 – Tuberculosis: diagnosis
Year: 2019
Identification of serum biomarkers associated with asthma phenotypes through Combinatorial Hexapeptide Ligand Libraries (CPLLs) and iTRAQ-coupled LC-MS/MS.
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019
The identification of asthma phenotypes by categorical PCA: Combinatorial analysis of clinical parameters and dysfunctional blood eosinophils
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Exploiting metabolomic approaches to aid in the diagnosis of lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016
LSC Abstract – Systemic and local metabolomics profiling reveals novel insights into the progression of emphysema
Source: International Congress 2016 – New therapies and therapeutic targets
Year: 2016
Novel proteomic biomarkers in the evaluation of childhood asthma
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept